Streetbeat News

Products Services

BYDDY

F

GM

LI

RIVN

TSLA

XPEV

Legacy automakers Ford (F) and General Motors (GM) are facing setbacks in their EV production, with Ford postponing the launch of its all-electric Ford Explorer and GM experiencing issues with its Ultium battery production. Meanwhile, Tesla (TSLA) has cut prices in China, intensifying competition. Rivian (RIVN) beat Q2 estimates and raised 2023 production guidance. The EV market in China also saw a slump in stocks of BYD (BYDDY), Li Auto (LI), and Xpeng (XPEV) following Tesla's price cut.

Portfolio Pulse from Upwallstreet

August 14, 2023 | 1:05 pm

BNMV

BitNile Metaverse, Inc. (NASDAQ:BNMV) announced the expansion of its social gaming experience on its platform, BitNile.com, with the launch of Blackjack on September 1, 2023. The company expects the popular casino game to increase revenue from the sale of in-world coins required to play the game. BitNile Metaverse previously introduced social gaming with the release of roulette and plans to add more games in the future.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:02 pm

LTRN

Lantern Pharma Inc. (NASDAQ:LTRN) has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its drug candidate LP-184, developed for the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT), a rare pediatric brain cancer. LP-184 is the first drug developed using Lantern's AI and machine learning platform, RADR®. The FDA has previously granted LP-184 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of pediatric patients with ATRT. The aggregate annual market potential of LP-184's target indications is estimated to be approximately $10+ billion.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:02 pm

TANH

Tantech Holdings Ltd (NASDAQ: TANH) announced that its subsidiary, Shangchi Automobile Co., Ltd., has signed a contract to export 20 school buses to Ecuador. This is the fourth order of school buses from Ecuador. The order represents a significant business opportunity for Tantech to expand its market presence and generate revenue.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:01 pm

RVNC

Revance Therapeutics has received FDA approval for DAXXIFY, a treatment for cervical dystonia, according to an SEC filing. The approval was announced on August 11, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:00 pm

ANIX

Anixa Biosciences (NASDAQ:ANIX) announced that its Chief Development Officer, Dr. Pamela D. Garzone, will present at the 8th Annual CAR-TCR Summit. The presentation will focus on the development of CAR-T for ovarian cancer and other solid tumors, and will detail the ongoing clinical trial (NCT05316129) in collaboration with Moffitt Cancer Center. The trial is a Phase I clinical trial of autologous T cells genetically engineered to target the follicle-stimulating hormone receptor (FSHR) in patients with recurrent ovarian cancer.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:58 pm

CLRB

Cellectar Biosciences anticipates top-line data from its WM CLOVER-WaM trial in the second half of 2023. The company remains on track for a product launch in 2024, assuming it receives New Drug Application (NDA) approval.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:57 pm

JUPW

Jupiter Wellness, Inc. (NASDAQ:JUPW) has signed a consulting agreement with David Gold and his firm D3M Licensing Group for the global launch of Safety Shot, the world's first rapid blood alcohol detoxification product. D3M has previously helped brands like Celsius Holdings, Inc. increase their market capitalization significantly. The hangover remedy market, where Safety Shot will be positioned, is projected to grow at a CAGR of 14.6% through 2028.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:56 pm

CMND

Clearmind Medicine Inc. (Nasdaq, CSE:CMND) has announced a collaboration with CTS Ltd., a leading pharmaceutical and consumer products company in Israel. The collaboration will allow Clearmind to expand its research and development capabilities, leverage CTS' expertise in manufacturing and marketing, and benefit from CTS' industry experience and guidance.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:53 pm

ASNS

The U.S. Air Force has chosen Actelis for the IoT networking modernization of a major Air Force base. Actelis was selected for its ability to deliver cyber-hardened, fast, fiber-grade performance using existing legacy network infrastructure. This is expected to save users tens to hundreds of thousands of dollars per site and months of installation and civil work compared to alternative networks based on 100% new Fiber-only infrastructure.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:52 pm